Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation (AFib) patients treated with the Affera™ family ...

Medtronic (NYSE:MDT) recently announced FDA approval of its OmniaSecure™ defibrillation lead, marking a key advancement in ...